Picture of Biogen logo

BIIB Biogen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Brief: Biogen To Introduce 28 Mg Vial At Same Price As 12 Mg Vial

March 30 (Reuters) - Biogen Inc BIIB.O:

BIOGEN WILL INTRODUCE 28 MG VIAL AT SAME PRICE AS 12 MG VIAL, RESULTING IN PARITY PRICING FOR PATIENTS IN THE MAINTENANCE PHASE- SPOKESPERSON

BIOGEN: DO NOT EXPECT ANY ADDITIONAL OUT-OF-POCKET COSTS FOR MAJORITY OF EXISTING SPINRAZA PATIENTS - SPOKESPERSON

BIOGEN: WAC OF SPINRAZA 12 MG & 28 MG VIALS IS THE SAME AT ABOUT $152,000, WAC OF 50 MG VIAL IS ABOUT $271,000 - SPOKESPERSON

Further company coverage: BIIB.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Biogen

See all news